Is there a link between antidepressants and breast and ovarian cancer? A new meta-analysis of 61 trials identified a connection in nearly 33 percent of the epidemiological and pre-clinical studies conducted between 1965 and 2010 found an association between cancer and antidepressants. And the link was stronger among women using selective serotonin reuptake inhibitors, or SSRIs. Moreover, the study found researchers with industry ties were significantly less likely than researchers without those affiliations to conclude antidepressants increase the risk of breast or ovarian cancer. The authors of the meta-analysis, which was published in PLoS Medicines, suggest the findings raise public health and policy issues, “because there is increasing evidence that financial ties among industry, investigators, and academic institutions can affect the research process.”
Read article at pharmalot.com And see antidepressants.